ferric chloride has been researched along with Parkinsonian Disorders in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Datla, KP; Dexter, DT; Gillies, GE; Murray, HE; Pillai, AV | 1 |
| Hong, J; Junxia, X; Ming, Q; Wenfang, C | 1 |
2 other study(ies) available for ferric chloride and Parkinsonian Disorders
| Article | Year |
|---|---|
Differences in dopaminergic neuroprotective effects of estrogen during estrous cycle.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Chlorides; Diestrus; Dopamine; Dopamine Plasma Membrane Transport Proteins; Estradiol; Estrogens; Estrous Cycle; Female; Ferric Compounds; Free Radicals; Homovanillic Acid; Injections; Membrane Glycoproteins; Membrane Transport Proteins; Nerve Tissue Proteins; Neuroprotective Agents; Neurotoxins; Oxidopamine; Parkinsonian Disorders; Proestrus; Rats; Rats, Wistar; Substantia Nigra | 2003 |
Dopamine release rather than content in the caudate putamen is associated with behavioral changes in the iron rat model of Parkinson's disease.
Topics: Animals; Apomorphine; Behavior, Animal; Caudate Nucleus; Chlorides; Deferoxamine; Disease Models, Animal; Dopamine; Drug Administration Routes; Female; Ferric Compounds; Iron; Iron Chelating Agents; Parkinsonian Disorders; Putamen; Rats; Rats, Sprague-Dawley | 2003 |